Several macrophage-targeted attempts to improve or prevent liver fibrosis have recently been reported, including dexamethasone-induced polarization into antifibrotic macrophages in murine models and galectin-3 inhibitors under clinical investigation (3, 20). Here, LGALS3 is linked to Hepatic fibrosis.